Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |